FDA Has Issued Documents Aimed at Guiding the Selection of Proprietary Names for Drugs
11 December 2020
The US Food and Drug Administration (FDA) has issued a pair of draft guidance documents aimed at guiding the selection of proprietary names for prescription and non-prescription drugs.
After the Second Dose, the Effectiveness of the “Sputnik V” Vaccine Increases to 96.2%
11 December 2020
The preliminary data obtained in the Russian Sputnik V coronavirus vaccine trials show that the efficiency of the jab stands at 69.3% after the first component is administered and 96.2% after the second, member of the independent monitoring committee examining the results of the vaccine’s clinical trials Ramil Khabriyev said Thursday (10 December).
GL Rapha Plans to Launch “Sputnik V” Vaccine Production in January 2021
10 December 2020
GL Rapha, one of the leading South Korean bio-tech companies, plans to launch full-scale production of Russia’s coronavirus vaccine Sputnik V in January 2021, Maeil Gyeongje newspaper reported.
EMA and HMA Have Published Their Joint Strategy for the Next Five Years
10 December 2020
EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.
RDIF and Ministry of Health of Kazakhstan Announce Cooperation on the “Sputnik V” Vaccine
09 December 2020
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and the Ministry of Health of Kazakhstan are pleased to announce a cooperation agreement designed to facilitate the registration, production and distribution of the world’s first registered vaccine against coronavirus – Sputnik V.
The Cost of Two Doses of the “Sputnik V” Vaccine is about 26 Dollars
09 December 2020
Russia’s Health Ministry has fixed the maximum cost price of the coronavirus vaccine Sputnik V at 1,942 rubles for two doses (about $26.20), Alexei Kuznetsov, an aide to the health minister, told on Saturday (5 December).
Registration for the COVID-19 Vaccination in Russia Will Open on December 4
08 December 2020
Registration for inoculation against the coronavirus in Moscow will open on the websites of the Mayor and the Moscow government on December 4; doctors, teachers, and social workers will be the first to get inoculated. Vaccination stations will open on December 5, Moscow Mayor Sergei Sobyanin wrote in his blog on Thursday (3 December).
08 December 2020
AbbVie, a research-based global biopharmaceutical company, and Frontier Medicines, Corp., a precision medicine company drugging challenging protein targets to develop breakthrough medicines that change the course of human diseases, announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative small molecule therapeutics against high-interest, difficult-to-drug protein targets.
Free Access to Supportive Pharmacopoeial Texts in the Field of COVID-19 Vaccines Is Open
07 December 2020
The EDQM is committed to supporting users during the coronavirus disease (COVID-19) pandemic – as well as contributing to the wider global effort to combat the virus – by openly sharing knowledge and providing access to relevant guidance/standards.
RDIF Announces Investment in Healthcare as a Strategic Priority
07 December 2020
The Russian Direct Investment Fund, (RDIF) Russia’s sovereign wealth fund, announces RDIF. Healthcare – an investment channel with a strategic focus on the implementation of projects in the healthcare sector. The fund has formed a specialized team of healthcare professionals to lead in developing the channel.
Failure to launch? Half of drugs rolled out since 2004 didn't live up to sales forecasts: report
22 January 2021
Pharma ad agencies weigh in with Biden vaccine campaign advice
21 January 2021
The pandemic and the pharmaceutical world
21 January 2021
Trial to evaluate inhaled COVID-19 therapy finishes enrolment
19 January 2021